Inactive Instrument
Quotes DiaMedica Inc. Toronto S.E.
Stocks
DMA
CA25253T1075
Biotechnology & Medical Research
|
End-of-day quote
Toronto S.E.
|
||
| - CAD | - |
|
| 11/08 | DiaMedica Therapeutics Inc., Q2 2026 Earnings Call, Aug 11, 2026 | |
| 11/08 | DiaMedica Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Stock exchange
Basic data
Market Cap (CAD)
64,18,87,034
Market Cap (USD)
45,02,79,569
Net sales (CAD)
0
Net sales (USD)
0
Free-Float
56.63%
Free-Float capitalization (CAD)
36,34,83,187
Free-Float capitalization (USD)
25,49,81,085
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | 0.00% | - | - | 45Cr | |
| +4.16% | +3.04% | +49.37% | +94.17% | 7.44TCr | |
| -3.11% | -3.53% | +21.92% | +74.60% | 5.93TCr | |
| +0.89% | -0.63% | +4.28% | +34.51% | 4.71TCr | |
| -0.91% | -4.48% | +26.39% | +33.21% | 4.29TCr | |
| -0.09% | +0.28% | +349.78% | +685.44% | 4.41TCr | |
| -1.22% | -1.96% | +2.49% | +98.20% | 4.08TCr | |
| -0.54% | +2.93% | +9.50% | +50.41% | 3.08TCr | |
| -2.68% | +5.11% | +33.11% | +19.50% | 2.93TCr | |
| +2.39% | -6.53% | -27.92% | +334.13% | 2.37TCr | |
| Average | -0.11% | -0.64% | +52.10% | +158.24% | 3.93TCr | |
| Weighted average by Cap. | +0.10% | -0.40% | +57.19% | +149.78% |
Historical Quotes: DiaMedica Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Price Extremes
- Stock Market
- Stocks
- DMAC Stock
- DMA Stock
- Quotes DiaMedica Inc.
Select your edition
All financial news and data tailored to specific country editions
